---
document_datetime: 2024-10-14 13:55:33
document_pages: 15
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/siklos-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: siklos-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 9.0138103
conversion_datetime: 2025-12-26 12:24:55.324009
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Siklos

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                             |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------|
| N/0064               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                            | 11/10/2024                          |                                             | PL                               |                                                                                                     |
| II/0061              | Update of section 4.5 of the SmPC in order to update information regarding the interference with certain Continuous Glucose Monitoring (CGM) sensors, based | 27/06/2024                          |                                             | SmPC and PL                      | SmPC new text Section 4.5 New text is added Interference with Continuous Glucose Monitoring systems |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                    | on a literature review. The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to update the list of local representatives in the Package Leaflet. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data   |            |            |                        | Hydroxycarbamide may falsely elevate sensor glucose results from certain continuous glucose monitoring (CGM) systems and may lead to hypoglycemia if sensor glucose results are relied upon to dose insulin. For more information, please refer to the Summary of Product Characteristics.   |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/1692/ 202306 | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                | 11/01/2024 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                            |
| IA/0060            | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                            | 22/12/2023 | n/a        |                        |                                                                                                                                                                                                                                                                                              |
| IA/0059            | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                           | 30/11/2023 | n/a        |                        |                                                                                                                                                                                                                                                                                              |
| T/0057             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                   | 30/06/2023 | 26/07/2023 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                              |
| IA/0056            | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                            | 28/04/2023 | n/a        |                        |                                                                                                                                                                                                                                                                                              |
| IAIN/0055          | A.1 - Administrative change - Change in the name                                                                                                                                                                                                                                                      | 27/01/2023 | 04/04/2023 | SmPC,                  |                                                                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

|                    | and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                              |            |            | Labelling and PL       |                                                                                                                                                                                                                                                                                                                                                                                                       |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/1692/ 202206 | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                 | 12/01/2023 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0053            | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                            | 05/09/2022 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                       |
| II/0051            | C.I.3.b Update of section 5.1 of the SmPC with the available paediatric data from the studies NOHARM and Escort HU according to the PAM-Leg 34. C.I.3.b - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Change(s) with new additional data submitted by the MAH | 22/04/2022 | 04/04/2023 | SmPC                   | SmPC new text The MAH has added text section 5.1 to summarize the paediatric data in children < 2 year old from the two randomised placebo-controlled clinical trials (BABY HUG and NOHARM) and subsequent cohort studies providing supporting efficacy and safety data (including data on the maximum tolerated dose). For more information, please refer to the Summary of Product Characteristics. |
| PSUSA/1692/ 202106 | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                 | 13/01/2022 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                     |
| IB/0049            | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                                                                         | 11/11/2021 | 16/12/2021 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

| II/0047            | Update of sections 4.8 and 5.1 of the SmPC to include relevant information in paediatric patients based on results from the uncontrolled study ESCORT HU. In addition, the Marketing authorisation holder (MAH) took the opportunity to update the list of local representatives for Croatia in the Package Leaflet. Furthermore, the PI is brought in line with the latest QRD template version 10.2.and some minor editorial changes are included. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one                                                                                                                                                        | 22/07/2021   | 16/12/2021   | SmPC and PL           | Please refer to Scientific Discussion 'Siklos-H-C-000689-II- 0047'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/1692/ 202006 | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 28/01/2021   | 28/01/2021   | SmPC                  | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1692/202006.                                                                                                                                                                                                                                                                                                                                                                                                                               |
| II/0045            | Update of sections 4.2, 4.4, 4.5, 4.6, 4.8, 4.9 and 5.1 of the SmPC as a consequence of the final study results of the non-interventional cohort study ESCORT-HU (European Sickle Cell Disease Cohort - Hydroxyurea) and harmonisation with other HU products. In addition, Annex II is amended to revise the information on the physician information pack and to add that pharmacists should receive targeted communication on the risk of medication error due to the confusion between the two strengths where both are available. The PIL is updated in accordance with the changes to the SmPC. The RMP (v. 20 revision 1) is updated to reflect the finalisation of the ESCORT- HU study and modifications on the risk minimisation | 09/07/2020   | 27/05/2021   | SmPC, Annex II and PL | SmPC new text: Sections 4.2 and 4.4: Additional changes include modification of the neutrophil count threshold requiring modification of treatment, modification of the frequency of blood count monitoring at initiation of treatment and removal of recommendation on continuous follow - up of the growth of treated children and adolescents. Section 4.6 The figures for cases of pregnancy were updated to reflect the data collected in ESCORT-HU without modifying the recommendation. Section 4.8 The figures for cases of undesirable effects were updated to |

<div style=\"page-break-after: always\"></div>

|                    | measures. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |                 | reflect the data collected in ESCORT-HU without modifying the recommendation. Section 4.9 The figures for cases of overdose were updated to reflect the data collected in ESCORT-HU without modifying the recommendation. For more information, please refer to the Summary of Product Characteristics.   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0046          | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 29/05/2020 | 27/05/2021 | Annex II and PL |                                                                                                                                                                                                                                                                                                           |
| PSUSA/1692/ 201906 | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 16/01/2020 | n/a        |                 | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                         |
| IA/0044/G          | This was an application for a group of variations. B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms | 20/11/2019 | n/a        |                 |                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| N/0042    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 29/07/2019   | 27/05/2021   | PL   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------|
| IA/0041/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.8 - Administrative change - Changes to date of the audit to verify GMP compliance of the manufacturer of AS B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test | 20/03/2019   | n/a          |      |

<div style=\"page-break-after: always\"></div>

| PSUSA/1692/ 201806   | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                         | 17/01/2019   | n/a        |                        | PRAC Recommendation - maintenance   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------------------------------|
| N/0040               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                               | 28/11/2018   | 27/05/2021 | PL                     |                                     |
| IA/0038              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                 | 31/05/2018   | 02/08/2018 | SmPC and PL            |                                     |
| IB/0036              | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                         | 02/03/2018   | n/a        |                        |                                     |
| PSUSA/1692/ 201706   | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                         | 11/01/2018   | n/a        |                        | PRAC Recommendation - maintenance   |
| IB/0035/G            | This was an application for a group of variations. B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings B.II.a.1.b - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in scoring/break lines intended to divide into equal doses | 17/11/2017   | 02/08/2018 | SmPC, Labelling and PL |                                     |

<div style=\"page-break-after: always\"></div>

|           | Immediate release tablets, capsules, suppositories and pessaries B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method   |            |            |                        | pharmaceutical form -   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------|
| IAIN/0033 | B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings                                                                                                                                                                                                 | 15/09/2017 | 02/08/2018 | SmPC and PL            |                         |
|           | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                   | 04/08/2017 | 02/08/2018 | SmPC, Labelling and PL | IAIN/0032/G             |
| II/0031/G | This was an application for a group of variations. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.1.g - Change in the specification parameters and/or limits of the finished product - Addition or replacement (excluding biological or immunological                           | 18/05/2017 | n/a        |                        |                         |

<div style=\"page-break-after: always\"></div>

|                    | product) of a specification parameter wit its corresponding test method as a result of a safety or quality issue B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)   |            |            |                        |                                                                                                                                                                                                                                                                       |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0030             | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                          | 23/02/2017 | 24/04/2017 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Siklos in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation, with unlimited validity. |
| PSUSA/1692/ 201606 | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                           | 12/01/2017 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                     |
| PSUSA/1692/ 201506 | Periodic Safety Update EU Single assessment - hydroxycarbamide (for centrally authorised product only)                                                                                                                                                                                                                                                                                           | 14/01/2016 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                     |
| IAIN/0026          | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                  | 11/08/2015 | n/a        |                        |                                                                                                                                                                                                                                                                       |
| PSUV/0025          | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                           | 09/01/2015 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                     |
| N/0024             | Minor change in labelling or package leaflet not                                                                                                                                                                                                                                                                                                                                                 | 14/07/2014 | 24/04/2017 | PL                     |                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|           | connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                          |            |            |             |                                                                                                                                                                                                                                                                                                                                                               |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUV/0020 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                   | 20/02/2014 | 23/04/2014 | SmPC and PL | The frequency of azoospermia and oligospermia in the SmPC/PL should be changed from 'very rare' to 'very common'. The proposed changes to sections 4.6 and 4.8 of the SmPC and the leaflet are detailed in Annex 1 of the appended assessment report. However, a further update to the SmPC might be needed, if final study results become available in 2014. |
| IB/0023   | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                               | 25/02/2014 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                               |
| IAIN/0022 | C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) in the safety database and/or major contractual arrangements for the fulfilment of PhV obligations, and/or change of the site undergoing PhV activities                                                                                                                                                                   | 20/02/2014 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                               |
| IA/0021/G | This was an application for a group of variations. B.II.a.3.b.1 - Changes in the composition (excipients) of the finished product - Other excipients - Any minor adjustment of the quantitative composition of the finished product with respect to excipients B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.III.1.a.2 - Submission of a new/updated or | 19/02/2014 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

|           | relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                        |            |            |                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0019   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                      | 12/10/2012 | 23/04/2014 | SmPC            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| R/0018    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                        | 19/04/2012 | 28/06/2012 | SmPC            | Based on the review of the available information the CHMP is of the opinion that the quality, the safety and the efficacy of Siklos continues to be adequately and sufficiently demonstrated and considers that the benefit/risk profile of this medicinal product continues to be favourable. The CHMP recommends the renewal of the Marketing Authorisation for Siklos, subject to the conditions and obligations as laid down in Annex II to the Opinion. The CHMP recommends that the renewal be granted for a further 5 years. The MAH is requested to submit yearly PSURs unless otherwise specified by the CHMP. |
| IA/0017/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites B.II.b.3.a - Change in the manufacturing process of the finished product - Minor change in the manufacturing process of an immediate release solid oral dosage form or oral solutions B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of | 26/01/2012 | 10/05/2012 | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

|         | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging   |            |     |                  |                                                                                                                                                                        |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0015 | - to replace the manufacturing site for the finished product B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 07/06/2011 | n/a |                  |                                                                                                                                                                        |
| N/0014  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 19/05/2011 | n/a | Labelling and PL | The MAH applied to delete some not legally required information in Annex IIIA, in order to accommodate the space problem raised by the trilingual labels. In addition, |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |            |                        | the Braille mentioned in the outer carton will be embossed in lower cases. Finally, additional minor linguistic changes have been proposed for DE, EL, ES, FR, MT, NL, PT and SK languages.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0016/G | This was an application for a group of variations. B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold | 11/05/2011 | n/a        | SmPC and PL            |                                                                                                                                                                                               |
| X/0005    | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 18/11/2010 | 28/02/2011 | SmPC, Labelling and PL |                                                                                                                                                                                               |
| IA/0013   | B.II.b.2.b.2 - Change to batch release arrangements and quality control testing of the FP - Including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                    | 19/11/2010 | n/a        | Annex II and PL        |                                                                                                                                                                                               |
| IA/0012/G | This was an application for a group of variations. B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur.                                                                                                                                                                                                                                                                                                                                                                                                   | 26/10/2010 | n/a        |                        |                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

|           | Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                            |            |     |                        |          |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|----------|
| IA/0009   | B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already manufacturer                                                                                                                                                                                                                                                                                                                                                                           | 09/09/2010 | n/a |                        | approved |
| IB/0008/G | This was an application for a group of variations. B.II.e.1.b.2 - Change in immediate packaging of the finished product - Type of container - Sterile medicinal products and biological/immunological medicinal products B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging | 21/07/2010 | n/a | SmPC, Labelling and PL | site     |
| N/0007    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 21/05/2010 | n/a | PL                     |          |

<div style=\"page-break-after: always\"></div>

| IA/0006   | IA_01_Change in the name and/or address of the marketing authorisation holder                                     | 27/01/2010   | n/a        | SmPC, Labelling and PL       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|-----------|-------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0004   | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                          | 05/05/2009   | n/a        |                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IA/0002   | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                    | 05/05/2009   | n/a        |                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0001   | Update of Detailed Description of the Pharmacovigilance System Changes to QPPV Update of DDPS (Pharmacovigilance) | 30/05/2008   | 07/07/2008 | SmPC, Annex II and Labelling | The MAH applied to update the Detailed Description of the Pharmacovigilance System further to a change in the management of the pharmacovigilance and of the Qualified Person for Pharmacovigilance (QPPV). Consequently, a new version of the risk Management plan has been issued to be signed by the new QPPV. Annex II has been updated using standard text and including the new version numbers of these documents. The marketing authorisation number was included in Annexes I and IIIA, as well as the date of first authorisation in Annex I. |